Theme: Accelerating Next Generation Vaccines for Global Health

Euro Vaccines 2017

Euro Vaccines 2017

Sessions/Tracks

Conference Series LLC look forward to welcoming all the participants across the globe to attend “16th Euro Global Summit and Expo on Vaccines & Vaccination” going to be held during June 19-21, 2017 in Paris, France. The conference highlights the theme “Accelerating Next Generation Vaccines for Global Health” covering all important aspects in Vaccines and therapeutics.

Euro Vaccines 2017 conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions.

Track 1: Human Vaccines - Infectious & Non Infectious Diseases

vaccine is an inactivated form of bacteria or virus that is injected into the body to simulate an actual infection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate an immune response by the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate the immune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands

Track 2: Vaccine Research & Development:

Vaccine Development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 3: Cancer Vaccines:

Immunotherapeutics is treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat. The main types of immunotherapy now being used to treat cancer include:

  1. Cancer vaccines
  2. Monoclonal antibodies
  3. Immune checkpoint inhibitors
  4. Other, non-specific immunotherapies

Some types of immunotherapy are also sometimes called biologic therapy or biotherapy.

In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and they’ll impact how we treat cancer in the future.

Immunotherapy includes treatments that work in different ways. Some boost the body’s immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. It’s used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands

Track 4: HIV Vaccines:

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A “preventive” vaccine would stop HIV infection occurring altogether, whereas a “therapeutic” vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV. 

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 5: Vaccines safety & Efficacy:

Vaccines are the best defense we have against serious, preventable, and sometimes deadly contagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may be health risk. Accurate information about the value of vaccines as well as their possible side-effects helps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used. Find out about what is done before and after vaccines are approved for use and what is known about the benefits and safety of specific vaccines. There is a lot of false information about vaccines safety on the Internet. This can be confusing. Discover the answers to common questions and concerns about vaccines.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands

Track 6: Vaccination for Pregnant Women:

Vaccines can help keep you and your growing family healthy. If you are pregnant or planning a pregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. All women who will be pregnant (any trimester) during the flu season should be offered this vaccine. Talk to your doctor to see if this applies to you. Tetanus/Diphtheria/Pertussis (Tdap): Tdap is recommended during pregnancy, preferably between 27 and 36 weeks' gestation, to protect baby from whooping cough.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 7: Childhood Vaccines:

Vaccination given to children is called children Immunization. It is currently recommended that all children receive vaccination against the infectious diseases unless the child has special circumstances, such as a compromised immune system or neurological disorders. In our mobile society, over a million people each day people travel to and from other countries, where many vaccine-preventable diseases remain relatively common. Without vaccines, epidemics of many preventable diseases could return, resulting in increased - and unnecessary - illness, disability, and death among children.

We have record or near record low levels of vaccine-preventable childhood diseases in the United States, but that does not mean these have disappeared. Many of the viruses and bacteria are still circulating in this country or are only a plane ride away. That’s why it’s important that children, especially infants and young children receive recommended immunizations on time.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands

Track 8: Vaccine Adjuvants & Delivery Technologies:

Vaccine adjuvants - is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccines ingredients that have been used in vaccines since the 1930s.  Small amounts of aluminum are added to help the body build stronger immunity against the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

Drug delivery systems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug delivery—such as transport in the circulatory system and drug movement through cells and tissues—they have contributed to the development of a number of new modes of drug delivery that have entered clinical practice.  Role of vaccine delivery technologies includes rational development of vaccines, achieving immunization goals, supporting best clinical practice.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 9: Immunization for Older Adults:

Vaccines are an important part of routine preventive care for older adults, but most adults don’t get their vaccines as recommended. Omitting vaccination leaves adults needlessly vulnerable to severe illnesses, long-term suffering and death from preventable infections. Vaccines are recommended for adults of all ages, they are particularly important for older persons who are at great risk of serious debilitating consequences and death from infectious diseases. Vaccination is particularly important for individuals living in nursing homes or assisted living facilities, as disease can spread easily among people in close proximity.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands

Track 10: Vaccines against Viral and Bacterial Diseases:

Most vaccines against viral infection are effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.

It is difficult for many of us today to appreciate the dangers of childhood viral infections.

Most of the vaccines in use against viruses are very effective at preventing disease. However, for a variety of reasons, they can fail:

  • The vaccine becomes inactive due to incorrect storage, if used past its expiry date, or if incorrectly administered.
  • Individuals unpredictably fail to produce an adequate immune response to the vaccine.
  • Vaccine immunity “fades” over time.

 The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.

Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.

Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available against tuberculosisdiphtheriatetanuspertussis, Haemophilus influenzae type B, cholera, typhoid, and Streptococcus pneumoniae.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 11: DNA Vaccines:

DNA vaccination is a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.

Vaccination consists of stimulating the immune system with an infectious agent, or components of an infectious agent, modified in such a manner that no harm or disease is caused, but ensuring that when the host is confronted with that infectious agent, the immune system can adequately neutralize it before it causes any ill effect. For over a hundred years vaccination has been effected by one of two approaches: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime the immune system.

The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing the immune response. Ultimately, the distinction between a sophisticated DNA vaccine and a simple viral vector may not be clear. Many aspects of the immune response generated by DNA vaccines are not understood. However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands

Track 12: HPV Vaccines:

Human Papillomavirus (HPV) vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.

These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.

Routine HPV Vaccination                                           

  • HPV vaccine is routinely recommended for girls 11 and 12 years of age
  • The HPV4 vaccine (the type recommended for prevention of genital warts in girls) may also be given in three doses to boys aged 9 to 26.

It is important for girls to get HPV vaccine before their first sexual contact -- because they have not been exposed to HPV.  For these girls, the vaccine can prevent almost 100% of disease caused by the four types of HPV targeted by the vaccine. However, if a girl or woman is already infected with a type of HPV, the vaccine will not prevent disease from that type. The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 13: Veterinary vaccines:

Veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Several vaccine types can de distinguished among the second-generation veterinary vaccines, depending whether they are live or inactivated, according to the strain of rabies virus used and the characteristics of the cell substrate chosen for viral replication. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parenterally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 14: Tuberculosis Vaccines:

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands

Track 15: Mucosal vaccines:

Most infectious agents enter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosal immune system(dispersed or organised into units such as Peyer’s patches in the intestine or the nasal-associated lymphoidtissue in the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 16: Vaccines for Vector-borne Diseases:

Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. Vector-borne diseases are among the most complex of all infectious diseases to prevent and control. Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines.

Historically, successful vector-borne disease prevention resulted from management or elimination of vector populations.  Malaria was driven out of the USA and most of Europe in this way. Where vector control has been consistently applied in the past, the results have been dramatic, especially with early efforts to control malaria by spraying the inside surfaces of houses with insecticides. Indoor Residual Spraying (IRS) and long-lasting insecticide treated bednets have been very effective over the last 10 years and are widely regarded as one of the main contributors to the more than 1 million lives saved.

In contrast to expenditure and effort on medicine, diagnostic and vaccine development, relatively little attention was given to vector control in the past.  The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands

Track 17: Human Preventive & Therapeutic Vaccines:

preventative vaccine is administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases like poliochicken poxmeasles, mumps, rubella, influenza (flu), and hepatitis A and B.

In addition to preventive vaccines, there are also “therapeutic vaccines”. These are vaccines that are designed to treat people who already have a disease. Some scientists prefer to refer to therapeutic vaccines as “therapeutic immunogens.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; 9th Annual World Congress of Vaccine, March 29-31, 2017 China; 6th Asian Vaccine Conference, April 27-29, 2017; 10th Conference on Global Health and Vaccination Research, 14-15 March 2017 Norway

Track 18: Plant-based vaccines:

Plant-based vaccines are recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oral drug delivery in the form of an edible vaccine. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, and animal vaccineprojects have given promising data in early phase trials targeting specific animal species.

The plant-based vaccine production method works by isolating a specific antigen protein, one that triggers a human immune response from the targeted virus. A gene from the protein is transferred to bacteria, which are then used to “infect” plant cells. The plants then start producing the exact protein that will be used for vaccinations. The flexibility of the plant expressed vaccine system, combined with its low cost and ability to massively scale may provide vaccine protection not only to citizens of the United States, but to many parts of the world that cannot currently afford vaccines. Other uses of plant expressed vaccines including the successful creation of edible bananas that protect against the Norwalk virus.

Vaccines Conferences | Immunology Conferences | World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 German; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017, 2017 Kuala Lumpur, Malaysia; World Vaccine Congress Washington 2017 10 - 12 April, USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The 2017 Florida Immunization Summit, February 2-4, 2017 USA; HIV Vaccines, March 26—30, 2017 USA; IVW 2017 – Influenza Vaccines for the World, 19-21 April 2017 Switzerland; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands





About Conference

Conference Series LLC look forward to welcoming all the participants across the globe to attend 16th Euro Global Summit and Expo on Vaccines & Vaccination going to be held during June 19-21, 2017 in Paris, France. The conference highlights the theme “Accelerating Next Generation Vaccines for Global Health” covering all important aspects in Vaccines and Vaccinations.

Euro Vaccines 2017 conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions.

Why to attend???

With members from around the world focused on learning about Vaccinology/Immunology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology/Vaccinology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology/Vaccinology are hallmarks of this conference.

Target Audience:

  • Vaccinology/Immunology Students, Scientists
  • Vaccinology/Immunology Researchers
  • Vaccinology/Immunology Faculty
  • Medical Colleges
  • Vaccinology/Immunology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Machinery Manufacturing Companies




Market Analysis

Conference Series LLC invites all the participants across the globe to attend “16th Euro Global Summit and Expo on Vaccines & Vaccination” going to be held during June 19-21, 2017 in Paris, France. The Theme of the conference is "Accelerating Next Generation Vaccines for Global Health" will explore the advances in Vaccines and vaccination. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Euro Vaccines 2017 amasses all the extroverts under one roof of current advances.

      Vaccinology is a major field in eradication of diseases. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and Vaccinology as they relate to immunization.

Market Analysis of Vaccines:

The global vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8% from 2014 to 2019.

The report segments this market on the basis of type, technology, disease indication, and end user. Among various end users, the pediatrics segment is expected to account for the largest share of the market and is expected to grow at the highest CAGR from 2014 to 2019. Growth in this segment can be attributed to the rising prevalence of diseases and the increasing number of initiatives taken by government organizations for vaccination programs.

Based on geography, the global vaccines market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth of this market is driven by factors such as increasing government support for vaccine development, rising company investments for vaccine research, and high prevalence of diseases.

Key players in the vaccines market include

  • Bavarian Nordic (Denmark)
  • CSL Limited (Australia)
  • Emergent BioSolutions Inc. (U.S.)
  • GlaxoSmithKline, plc. (U.K.)
  • Johnson and Johnson (U.S.)
  • MedImmune, LLC (U.S.)
  • Merck and Company (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (U.S.)
  • Sanofi Pasteur (France)




Past Conference Report

Euro Vaccines 2016

Conference Series LLC hosted the 10th Euro Global Summit and Expo on Vaccines & Vaccination at Rome, Italy during June 16-18, 2016. The conference was organized with a focus on the theme “Transforming Health through Vaccine Innovations” and was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.

Euro Vaccines 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Vaccines and Therapeutics.

Conference Series LLC would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Euro Vaccines 2016:

Giulio Filippo Tarro, Foundation T. & L. de Beaumont Bonelli for Cancer Research, Italy
Van Regenmortel Marc Hubert Victor, University of Strasbourg, France
Adan Rios, PhotoImmune Biotechnology Inc., USA
Andrew Lees, Fina Biosolutions LLC, USA
Rene Labatut, Sanofi Pasteur, France
Timothy R Fouts, Profectus Biosciences Inc., USA
Prakash Bhuyan, Inovio Pharmaceuticals, USA
Emmanuel Drouet, Université Grenoble-Alpes, France

Conference Series LLC on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavours.

Conference Series LLC also took the privilege of felicitating Euro Vaccines 2016 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs whose support made conference a great success.

Euro Vaccines 2016 conference was a great success with the support of International multi professional steering committee and coordinated by Journal of Vaccines & Vaccination, Journal of Clinical & Cellular Immunology and Immunome Research. With the enormous feedback from the participants and supporters of Euro Vaccines 2016, Conference Series LLC is glad to announce 16th Euro Global Summit and Expo on Vaccines & Vaccination June 19-21, 2017 Paris, France.

Let us meet again @ Euro Vaccines 2017


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 19-21, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
eurovaccines@conferenceseries.net
Sponsors / Exhibiting / Advertising.
eurovaccines@vaccineconferences.com
General Queries.
eurovaccines@vaccineconference.com

View Proceedings of Previous Conferences

Euro Vaccines 2016
Euro Vaccines 2015
Vaccines Asia Pacific 2015
Dubai Vaccines 2015
Authorization Policy

By registering for the conference you grant permission to Conferenceseries Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.